A detailed history of Dt Investment Partners, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Dt Investment Partners, LLC holds 500 shares of BNTX stock, worth $49,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$49,860
Previous $40,000 47.5%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$127.65 - $183.11 $63,825 - $91,555
500 New
500 $67,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.2B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Dt Investment Partners, LLC Portfolio

Follow Dt Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dt Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dt Investment Partners, LLC with notifications on news.